Additive manufacturing, commonly known as 3D printing, has emerged as a revolutionary technology within the biopharmaceutical industry, offering considerable benefits. One of the most compelling advantages of additive manufacturing is its potential to optimize cleanroom space through the
October 23, 2024The biopharmaceutical industry is undergoing a significant transformation, driven by the need for speed, safety, and cost-efficiency in therapeutic production. The advent of new modalities like cell and gene therapies has added layers of complexity to the already intricate production pipelines. As
October 16, 2024The pharmaceutical packaging industry stands at the precipice of a significant transformation. With an anticipated growth from $110.55 billion in 2024 to $176.94 billion by 2032, driven by the increasing prevalence of biologics, stringent regulations, and the menace of drug counterfeiting, it is
October 14, 2024The biopharmaceutical industry is undergoing a significant transformation as it seeks to develop affordable treatments for unmet medical needs. Amidst this change, manufacturers are being pushed to cut costs and implement sustainable practices. Tosoh Bioscience stands out as a leader in sustainable
October 9, 2024In a significant step towards fostering environmental responsibility in the pharmaceutical sector, Tower Cold Chain has launched a new sustainability hub designed to help pharmaceutical manufacturers improve their environmental, social, and governance (ESG) practices. This initiative highlights the
September 30, 2024In a move that promises to set new standards in supply chain sustainability, DHL Supply Chain has joined forces with biopharmaceutical company Boehringer Ingelheim to transform its warehousing and logistics operations in Australia and New Zealand. The partnership aims to enhance efficiency,
September 3, 2024